InsiderTrades

Form 4 for COSM Cosmos Health Inc.

Accepted 2022-10-24 00:00:00 ET · period of report 2022-10-20 · accession 0001477932-22-007869 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2022-10-24 2022-10-20 COSM Siokas Grigorios CEO, Dir, 10% P - Purchase $0.12 +12.50M 19.33M +183% +$1.50M
D 2022-10-24 2022-10-20 COSM Siokas Grigorios CEO, Dir, 10% H - Exp Long $0.62 -2.65M 0 -100% -$1.65M
DM 2022-10-24 2022-10-20 COSM Siokas Grigorios CEO, Dir, 10% P - Purchase $0.12 +30.31M 5.31M New +$3.64M

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock, $.001 par value 2022-10-20 P A 12,500,000 $0.12 19,334,168 D — — (F1) Mr. Siokas purchased 12,500,000 shares of Common Stock pursuant to a Securities Purchase Agreement dated as of October 17, 2022 (the "SPA"), which were sold to him pursuant to Registration Statement Nos. 333-267505 and 333-267917.
2 Derivative Common Warrants 2022-10-20 H D 2,654,782 $0.62 0 D $0.62 · 2022-08-28 to 2027-08-28 2,654,782 Common Stock (F2) Mr. Siokas exchanged these warrants pursuant to a Warrant Exchange Agreement dated as of October 3, 2022, subject to a beneficial ownership limitations of 9.99%.
3 Derivative Series B Common Warrants 2022-10-20 P A 12,500,000 $0.12 12,500,000 D $0.12 · 2022-10-20 to 2029-10-20 12,500,000 Common Stock (F4) These warrants were acquired pursuant to the SPA and Registration Statements described in Note (1) above.
4 Derivative Series A Common Warrants 2022-10-20 P A 12,500,000 $0.12 12,500,000 D $0.12 · 2022-10-20 to 2024-10-20 12,500,000 Common Stock (F4) These warrants were acquired pursuant to the SPA and Registration Statements described in Note (1) above.
5 Derivative Exchange Warrants 2022-10-20 P A 5,309,564 $0.12 5,309,564 D $0.12 · 2022-10-20 to 2029-10-20 5,309,564 Common Stock (F3) Mr. Siokas acquired these warrants on October 20, 2022 pursuant to a Warrant Exchange Agreement set forth in Note 2 above.